Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Phase 2a Trial of Vutiglabridin in Early Parkinson’s Disease
KCT0010348Phase 2Recruiting
- Sponsor
- Glaceum
- Start
- Aug 2024
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of vutiglabridin in Parkinson's disease (PD), sponsored by Glaceum. Started Aug 2024; status: recruiting.
02
Drugs
vutiglabridin
03
Conditions
Parkinson's disease (PD)
Beyond the preview
Go deeper on KCT0010348.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on KCT0010348.